Limited Submission Reminder: W.M. Keck Foundation Research Program
Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).
The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.
Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.
Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:
- Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
- Have the potential to develop breakthrough technologies, instrumentation or methodologies.
- Have few, if any, peer groups pursuing comparable or related work.
- Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
- Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
- Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
- Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
Howard Hughes Medical Institute, Bill and Melinda Gates Foundation and Simmons Foundation
The Howard Hughes Medical Institute, Bill and Melinda Gates Foundation and Simmons Foundation have partnered to create a new program, the 2016 Faculty Scholar Program, designed to support early-career scientists. The Faculty Scholars competition is open to basic researchers and physician scientists at more than 220 eligible institutions, including Case Western Reserve. The competition seeks scholars who will apply molecular, genetic, computational and theoretical approaches to fundamental problems in diverse areas of biology.
• PhD and/or MD (or the equivalent).
• Tenured or tenure-track position as an assistant professor or higher academic rank at an eligible U.S. institution, or, if at an eligible institution that has no tenure track, an appointment that reflects a significant institutional commitment. Federal government employees are not eligible.
• More than 4, but no more than 10, years of post-training, professional experience. To meet this requirement, the applicant’s post-training, professional experience must have begun no earlier than June 1, 2005, and no later than July 1, 2011.
• Principal investigator or Co-Principal investigator on at least one active, nationally competitive grant with an initial term of two or more years at some point from April 1, 2013 through July 1, 2015. Career development grants qualify. Multi-investigator grants may qualify.
• Up to 70 awardees will receive non-renewable grants ranging from $100k to $400k per year over 5 years ($500k - $2M per award).
• Faculty Scholars are required to devote at least 50% of their total effort to the direct conduct of research.
• Scholars conducting research at the interface of the biological and physical sciences are encouraged to apply.
• Scholars studying biological questions emerging from and applicable to global human health problems, including malaria, tuberculosis, HIV, and other diseases that disproportionately affect individuals living in low resource settings are encouraged to apply
• Women and minorities under-represented in the biomedical and biological sciences are strongly encouraged to apply.
Application Deadline: July 28, 2015
For more information visit the Howard Hughes Medical Institute website.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Duchenne Muscular Dystrophy Investigator-Initiated Research Award
DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
DoD Duchenne Muscular Dystrophy Translational Leverage Award
DoD Lung Cancer Concept Award
Community-Based Research Consult Service
The Case Center for Reducing Health Disparities is funded by the National Institutes of Health to offer a variety of services to faculty members, health care providers, student researchers, and community organizations. One of our many services include a Community-Based Research Consult Service to help researchers and organizations develop quality research.
The consult service has expertise in areas including, but not limited to: research project development, IRB application process, grants assistance and funding, survey development and refinement, needs assessment, data collection, program evaluation, best practices, focus group development, recruitment strategies, dissemination of findings, and Spanish Translation.
For additional information, visit the Center for Reducing Health Disparities website: http://www.reducedisparity.org/.
For assistance, please contact Katrice Cain (216-778-8467 or email@example.com) or Mary Ellen Lawless (216-778-1304 or firstname.lastname@example.org).
Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:
- For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)
- Addressable with peptides and/or proteins
- Exploratory, discovery and/or preclinical in nature
The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.
Application Deadline: July 1st, 2015
For more information visit the Ferring Pharmaceuticals webpage.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
email@example.com no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be